2021年最新SCI期刊影响因子查询系统
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 期刊详细信息
基本信息
期刊名称 | PHARMACOEPIDEMIOLOGY AND DRUG SAFETY PHARMACOEPIDEMIOLOGY AND DRUG SAFETY |
---|---|
期刊ISSN | 1053-8569 |
期刊官方网站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1099-1557 |
是否OA | 否 |
出版商 | John Wiley and Sons Ltd |
出版周期 | Bimonthly |
始发年份 | 1992 |
年文章数 | 170 |
最新影响因子 | 2.732(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学3区 | PHARMACOLOGY & PHARMACY 药学3区 | 否 | 否 |
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH 公共卫生、环境卫生与职业卫生3区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 2.51 | 1.519 | 1.131 |
Medicine Epidemiology |
42 / 89 | 52% |
|||
Medicine Pharmacology (medical) |
76 / 232 | 67% |
补充信息
自引率 | 7.20% |
---|---|
H-index | 77 |
SCI收录状况 |
Science Citation Index
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1053-8569%5BISSN%5D |
投稿指南
期刊投稿网址 | http://mc.manuscriptcentral.com/pds |
---|---|
收稿范围 | The aim of Pharmacoepidemiology and Drug Safety is to provide an international forum for the communication and evaluation of data, methods and opinion in the discipline of pharmacoepidemiology. The Journal publishes peer-reviewed reports of original research, invited reviews and a variety of guest editorials and commentaries embracing scientific, medical, statistical, legal and economic aspects of pharmacoepidemiology and post-marketing surveillance of drug safety. Appropriate material in these categories may also be considered for publication as a Brief Report. Particular areas of interest include: design, analysis, results, and interpretation of studies looking at the benefit or safety of specific pharmaceuticals, biologics, or medical devices, including studies in pharmacovigilance, postmarketing surveillance, pharmacoeconomics, patient safety, molecular pharmacoepidemiology, or any other study within the broad field of pharmacoepidemiology; comparative effectiveness research relating to pharmaceuticals, biologics, and medical devices. Comparative effectiveness research is the generation and synthesis of evidence that compares the benefits and harms of alternative methods to prevent, diagnose, treat, and monitor a clinical condition, as these methods are truly used in the real world; methodologic contributions of relevance to pharmacoepidemiology, whether original contributions, reviews of existing methods, or tutorials for how to apply the methods of pharmacoepidemiology; assessments of harm versus benefit in drug therapy; patterns of drug utilization; relationships between pharmacoepidemiology and the formulation and interpretation of regulatory guidelines; evaluations of risk management plans and programmes relating to pharmaceuticals, biologics and medical devices. |
收录体裁 | |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |